This is also reflected in the different medications predominantly taken by patients with either type 1 or type 2 diabetes, as there is a higher prevalence of DD in patients with diabetes taking metformin compared to patients with diabetes taking insulin. This evidence concerns the gene INS and type 2 diabetes mellitus.